ConductScience.org, home

Paper508461

Diazoxide in treatment of primary pulmonary hypertension.

Rubino JM and 1 other. Br Heart J, 1979. Cited by 44 papers, by iCite.

Cite this record

ConductScience Library. Diazoxide in treatment of primary pulmonary hypertension. Papers, record 508461. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/508461

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Diazoxide in treatment of primary pulmonary hypertension.
PubMed
Journal
Br Heart J
PubMed
Year
1979
PubMed
Publication types
Case Reports, Letter
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
2.42
iCite
Revised in PubMed
2019-05-03
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rubino JMJ M
2Schroeder JSJ S

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DiazoxideMajor topic
Hypertension, PulmonaryMajor topic
Adult
Female
Humans
Injections, Intra-Arterial
Pulmonary Artery

Source PubMed

Download CSV of topics

References3

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14520400Influence of intravenous injection rate on protein binding and vascular activity of diazoxide.Ann N Y Acad Sci1973https://conductscience.org/library/papers/4520400PubMed
24750336Primary pulmonary hypertension: a fatality during pulmonary angiography. Clinical conference from Boston University School of Medicine.Chest1973https://conductscience.org/library/papers/4750336PubMed
35375043[Effect of diazoxide, a new bllood pressure lowering substance, on the general and pulmonary circulatory system in hypertension].Z Kreislaufforsch1969https://conductscience.org/library/papers/5375043PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
28632001Vasodilator responsiveness in idiopathic pulmonary arterial hypertension: identifying a distinct phenotype with distinct physiology and distinct prognosis.Pulm Circ2017https://conductscience.org/library/papers/28632001PubMed
6743418Detrimental effects of verapamil in patients with primary pulmonary hypertension.Br Heart J1984https://conductscience.org/library/papers/6743418PubMed
3966945Management of primary pulmonary hypertension.Br Heart J1985https://conductscience.org/library/papers/3966945PubMed
3814459Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxide.Br Heart J1987https://conductscience.org/library/papers/3814459PubMed
3099910Primary pulmonary hypertension.Br Med J (Clin Res Ed)1986https://conductscience.org/library/papers/3099910PubMed
2868878Drug treatment of primary pulmonary hypertension.Drugs1986https://conductscience.org/library/papers/2868878PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/508461

GET https://conductscience.org/api/papers/v1/508461/authors